D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Heritage Insurance Holdings
HRTG
$842M
| $232K | ﹤0.01% |
14,513
-1,354
| -9% | -$24.7K |
|
|
RPRX
3102
DELISTED
Repros Therapeutics Inc.
RPRX
| $232K | ﹤0.01% |
239,548
-30,561
| -11% | -$29.8K |
|
3103
Avient
AVNT
$3.45B
| $231K | ﹤0.01% |
+7,630
| New | +$210K |
|
3104
Northrop Grumman
NOC
$77B
| $231K | ﹤0.01% |
1,168
-11,606
| -91% | -$2.19M |
|
3105
Opko Health
OPK
$921M
| $231K | ﹤0.01% |
22,200
-555,153
| -96% | -$5.07M |
|
|
STML
3106
DELISTED
Stemline Therapeutics, Inc.
STML
| $231K | ﹤0.01% |
49,597
-3,432
| -6% | -$16.8K |
|
3107
Alamos Gold
AGI
$12.4B
| $230K | ﹤0.01% |
43,407
+9,022
| +26% | +$37K |
|
|
BIOL
3108
DELISTED
Biolase, Inc.
BIOL
| $230K | ﹤0.01% |
14
| – | – |
|
|
CAS
3109
DELISTED
A M Castle & Co
CAS
| $230K | ﹤0.01% |
85,340
-20,426
| -19% | -$42.8K |
|
3110
FirstCash
FCFS
$8.55B
| $229K | ﹤0.01% |
4,970
-2,032
| -29% | -$82K |
|
3111
CALL
ArcelorMittal
MT
$50.4B
| $229K | ﹤0.01% |
+16,667
| New | +$161K |
|
|
3112
PUT
ArcelorMittal
MT
$50.4B
| $229K | ﹤0.01% |
16,667
-5,200
| -24% | -$50.2K |
|
3113
Q2 Holdings
QTWO
$3.42B
| $229K | ﹤0.01% |
9,535
-56,245
| -86% | -$1.21M |
|
|
TTOO
3114
DELISTED
T2 Biosystems, Inc
TTOO
| $228K | ﹤0.01% |
5
+2
| +67% | +$88.4K |
|
|
UAM
3115
DELISTED
Universal American Corp
UAM
| $227K | ﹤0.01% |
31,757
+5,907
| +23% | +$38.4K |
|
3116
Mid-America Apartment Communities
MAA
$15.6B
| $226K | ﹤0.01% |
2,209
| – | – |
|
|
NVTA
3117
DELISTED
Invitae Corporation
NVTA
| $226K | ﹤0.01% |
+22,136
| New | +$176K |
|
|
BHBK
3118
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $226K | ﹤0.01% |
16,498
+3,187
| +24% | +$44.7K |
|
3119
Chubb
CB
$140B
| $225K | ﹤0.01% |
1,891
-16,060
| -89% | -$1.85M |
|
3120
CALL
Cleveland-Cliffs
CLF
$6.81B
| $225K | ﹤0.01% |
75,000
-250,000
| -77% | -$524K |
|
|
NSM
3121
DELISTED
Nationstar Mortgage Holdings
NSM
| $225K | ﹤0.01% |
+22,723
| New | +$242K |
|
3122
First Industrial Realty Trust
FR
$8.88B
| $224K | ﹤0.01% |
+9,860
| New | +$208K |
|
3123
Campbell Soup
CPB
$6.51B
| $222K | ﹤0.01% |
3,476
-96,493
| -97% | -$5.67M |
|
3124
Howard Hughes
HHH
$3.93B
| $222K | ﹤0.01% |
2,203
-104
| -5% | -$9.56K |
|
|
PNNT
3125
Pennant Park Investment Corp
PNNT
$215M
| $220K | ﹤0.01% |
+36,383
| New | +$208K |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.